Amniotic Membranes Market: North America to Remain Dominant Regional Market in Terms of Revenue During the Forecast Period: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028

Amniotic Membranes Market: North America to Remain Dominant Regional Market in Terms of Revenue During the Forecast Period: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028

This Future Market Insights (FMI) report examines the global amniotic membrane market for the period 2013–2028. The primary objective of the report is to offer insights into market opportunity for amniotic membrane and provide assessment of pipeline developments in amniotic membrane market.

The global amniotic membrane market has seen changes in landscape in the last decade. The key accomplishment in unlocking the potential for amniotic membrane to be used for the treatment of defects of the corneal epithelia has been attained by initiating mass extraction and storage of amniotic membrane for medical applications.

The market for amniotic membrane is primarily driven by increased adoption of amniotic membrane for various applications, financial investments for development of innovative amniotic membrane, increasing focus on tissue-cell and stem cell research, unmet clinical needs fuelling demand for regenerative therapies, increase in regulatory harmonization to accelerate pace of product approvals, rise in number of amniotic membrane transplants, etc. However, lack of skilled/experienced professionals, high gestation period and time-to-market due to lengthy clinical trials, lack of standardized guidelines on tissue and bio-medical engineering are the factors deterring the growth of the global market.

The Global Amniotic Membrane Market has been Segmented Based on:

Product Type

Application

End User

Region

The report analyses the global amniotic membrane market in terms of value (US$ Mn). The report begins with the market definition and explaining different types of amniotic membrane types available in the market. This section also provides an overview on dermal substitute market, to which amniotic membrane is a sub-part. The market view point section includes FMI’s analysis on key trends, drivers, opportunities and macro factors influencing the global market. Opportunity analysis provided in the section allows to better equip with crystal clear decision-making insights. Pipeline analysis provided in the subsequent section helps to identify future rivals in the global market.

The report analyses the market based on regions and presents the forecast in terms of value (US$ Mn) for the next 10 years. The regions covered in the report include:

North America

Latin America

Western Europe

Eastern Europe

Asia Pacific Excluding Japan & China (APEJC)

Japan

China

The Middle East and Africa (MEA)

Each of these sections analyse the regional market by product type, application, end users and country. The regional introductory section provides key insights on market dynamics for each region. The section is mainly designed to provide current scenario of the amniotic membrane market in the region and forecast for 2018–2028. The representative market participants section gives the list of companies operating in each region, competitive landscape and intensity map of their presence in each region.

To arrive at the market size, we have used our in-house epidemiology data-based model to estimate the amniotic membrane market size. We have adopted bottom-up approach to forecast the amniotic membrane market. The weighted average selling price is considered to estimate the market size of various product type mentioned in the scope of the study. The country price is captured with the local currency. The local currency figures are then converted to USD to offer forecasts in a consistent currency standard. Furthermore, FMI has also considered the latest annual exchange rate to reflect the impact of the most recent economic conditions of the countries. Prices considered in the models are standardized based on the type of amniotic membrane allografts used to treat patients.

The forecast presented in the report provides total revenue of currently approved amniotic membrane products over 2018–2028. In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global market.

In the next section of the report, the ‘Competitive Landscape’ is included to provide report audiences with a dashboard view and to access the key differentiators among the competitor firms. The market structure analysis provides tier-wise breakdown of total market revenue. The section also provides company share analysis and brand share analysis for the key market players. This section is primarily designed to provide clients with an objective and detailed comparative assessment of product offerings and strategies of key providers specific to the market segments. Detailed profiles of players operating in the global amniotic membrane market are also provided in the report, which highlight company description, overview, product/segment overview, SWOT analysis, financial information, key developments related to market and strategic overview. The key players covered in the report include Integra LifeSciences Inc., MiMedx Group, Inc., Alliqua BioMedical, Inc., Skye Biologics Inc., Katena Products, Inc., Tissue-Tech Inc., Amnio Technology, LLC, Applied Biologics LLC, and Human Regenerative Technologies, LLC, among others.

The next section of report analyses the market based on product types and forecast is provided in terms of value for the next 10 years. The product types covered in the report include:

Cryopreserved Amniotic Membrane

Lyophilized Amniotic Membrane

The next section of the report provides analysis based on application and the forecast is provided in terms of value for the next 10 years. The applications covered in the report include:

Surgical Wound

Ophthalmology

Others

The next section of report analyses the market based on the end users of amniotic membrane products and provides the forecast in terms of value for the next 10 years. End users covered in the report include:

Hospitals

Specialized Clinics

Ambulatory Surgical Centres

Academic Research Centres

Another key feature of this report is the analysis of the key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective of the products. To understand the key growth segments, Future Market Insights provides the ‘Attractiveness Index’ analysis, which helps to identify real market opportunities.


1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Amniotic Membrane Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
4. Market Background
4.1. Value Chain
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Trends
4.2.4. Opportunity Analysis
4.3. Regulatory Scenario
5. Global Economic Outlook
5.1. Gross Domestic Product by Region & Country, 2006 – 2021
5.2. Global Market Outlook and Share of Amniotic Membrane in Global Market
6. Key Inclusions
6.1. Key Manufacturer List
6.2. Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue Based Products
7. North America Amniotic Membrane Market Analysis 2013–2017 and Forecast 2018–2028
7.1. Introduction
7.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2017
7.2.1. U.S.
7.2.2. Canada
7.3. Market Size (US$ Mn) Forecast By Country, 2018–2028
7.4. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Product Type, 2013–2017
7.4.1. Cryopreserved Amniotic Membrane
7.4.2. Lyophilization Amniotic Membrane
7.5. Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2018–2028
7.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
7.6.1. Surgical Wound
7.6.2. Ophthalmology
7.6.3. Others
7.7. Market Size (US$ Mn) Forecast By Application, 2018–2028
7.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
7.8.1. Hospitals
7.8.2. Specialized Clinics
7.8.3. Ambulatory Surgical Centers
7.8.4. Academic Research Centers
7.9. Market Size (US$ Mn) Forecast By End User, 2018–2028
7.10. Market Attractiveness Analysis
7.10.1. By Country
7.10.2. By Product Type
7.10.3. By Application
7.10.4. By End User
7.11. Key Market Participants – Intensity Mapping
7.12. Drivers and Restraints – Impact Analysis
8. Latin America Amniotic Membrane Market Analysis 2013–2017 and Forecast 2018–2028
8.1. Introduction
8.2. Historical Market Size (US$ Mn) Trends Analysis By Country, 2013–2017
8.2.1. Argentina
8.2.2. Brazil
8.2.3. Mexico
8.2.4. Rest of Latin America
8.3. Market Size (US$ Mn) Forecast By Country, 2018–2028
8.4. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Product Type, 2013–2017
8.4.1. Cryopreserved Amniotic Membrane
8.4.2. Lyophilization Amniotic Membrane
8.5. Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2018–2028
8.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
8.6.1. Surgical Wound
8.6.2. Ophthalmology
8.6.3. Others
8.7. Market Size (US$ Mn) Forecast By Application, 2018–2028
8.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
8.8.1. Hospitals
8.8.2. Specialized Clinics
8.8.3. Ambulatory Surgical Centers
8.8.4. Academic Research Centers
8.9. Market Size (US$ Mn) Forecast By End User, 2018–2028
8.10. Market Attractiveness Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.10.4. By End User
8.11. Key Market Participants – Intensity Mapping
8.12. Drivers and Restraints – Impact Analysis
9. Western Europe Amniotic Membrane Market Analysis 2013–2017 and Forecast 2018–2028
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
9.2.1. Germany
9.2.2. U.K.
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Western Europe
9.3. Market Size (US$ Mn) Forecast By Country, 2018–2028
9.4. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Product Type, 2013–2017
9.4.1. Cryopreserved Amniotic Membrane
9.4.2. Lyophilization Amniotic Membrane
9.5. Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2018–2028
9.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
9.6.1. Surgical Wound
9.6.2. Ophthalmology
9.6.3. Others
9.7. Market Size (US$ Mn) Forecast By Application, 2018–2028
9.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
9.8.1. Hospitals
9.8.2. Specialized Clinics
9.8.3. Ambulatory Surgical Centers
9.8.4. Academic Research Centers
9.9. Market Size (US$ Mn) Forecast By End User, 2018–2028
9.10. Market Attractiveness Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By End User
9.11. Key Market Participants – Intensity Mapping
9.12. Drivers and Restraints – Impact Analysis
10. Eastern Europe Amniotic Membrane Market Analysis 2013–2017 and Forecast 2018–2028
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
10.2.1. Russia
10.2.2. Poland
10.2.3. Rest of Eastern Europe
10.3. Market Size (US$ Mn) Forecast By Country, 2018–2028
10.4. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Product Type, 2013–2017
10.4.1. Cryopreserved Amniotic Membrane
10.4.2. Lyophilization Amniotic Membrane
10.5. Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2018–2028
10.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
10.6.1. Surgical Wound
10.6.2. Ophthalmology
10.6.3. Others
10.7. Market Size (US$ Mn) Forecast By Application, 2018–2028
10.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
10.8.1. Hospitals
10.8.2. Specialized Clinics
10.8.3. Ambulatory Surgical Centers
10.8.4. Academic Research Centers
10.9. Market Size (US$ Mn) Forecast By End User, 2018–2028
10.10. Market Attractiveness Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By End User
10.11. Key Market Participants – Intensity Mapping
10.12. Drivers and Restraints – Impact Analysis
11. Asia Pacific Excluding Japan Amniotic Membrane Market Analysis 2013–2017 and Forecast 2018–2028
Market forecast and analysis in China, India, Australia & New Zealand, ASEAN and rest of Asia Pacific excluding Japan
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
11.2.1. India
11.2.2. Australia and New Zealand
11.2.3. ASEAN Countries
11.2.4. Rest of Asia Pacific
11.3. Market Size (US$ Mn) Forecast By Country, 2018–2028
11.4. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Product Type, 2013–2017
11.4.1. Cryopreserved Amniotic Membrane
11.4.2. Lyophilization Amniotic Membrane
11.5. Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2018–2028
11.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
11.6.1. Surgical Wound
11.6.2. Ophthalmology
11.6.3. Others
11.7. Market Size (US$ Mn) Forecast By Application, 2018–2028
11.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
11.8.1. Hospitals
11.8.2. Specialized Clinics
11.8.3. Ambulatory Surgical Centers
11.8.4. Academic Research Centers
11.9. Market Size (US$ Mn) Forecast By End User, 2018–2028
11.10. Market Attractiveness Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By End User
11.11. Key Market Participants – Intensity Mapping
11.12. Drivers and Restraints – Impact Analysis
12. Japan Amniotic Membrane Market Analysis 2013–2017 and Forecast 2018–2028
12.1. Introduction
12.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Product Type, 2013–2017
12.2.1. Cryopreserved Amniotic Membrane
12.2.2. Lyophilization Amniotic Membrane
12.3. Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2018–2028
12.4. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
12.4.1. Surgical Wound
12.4.2. Ophthalmology
12.4.3. Others
12.5. Market Size (US$ Mn) Forecast By Application, 2018–2028
12.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
12.6.1. Hospitals
12.6.2. Specialized Clinics
12.6.3. Ambulatory Surgical Centers
12.6.4. Academic Research Centers
12.7. Market Size (US$ Mn) Forecast By End User, 2018–2028
12.8. Market Attractiveness Analysis
12.8.1. By Product Type
12.8.2. By Application
12.8.3. By End User
12.9. Key Market Participants – Intensity Mapping
12.10. Drivers and Restraints – Impact Analysis
13. China Amniotic Membrane Market Analysis 2013–2017 and Forecast 2018–2028
13.1. Introduction
13.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Product Type, 2013–2017
13.2.1. Cryopreserved Amniotic Membrane
13.2.2. Lyophilization Amniotic Membrane
13.3. Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2018–2028
13.4. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
13.4.1. Surgical Wound
13.4.2. Ophthalmology
13.4.3. Others
13.5. Market Size (US$ Mn) Forecast By Application, 2018–2028
13.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
13.6.1. Hospitals
13.6.2. Specialized Clinics
13.6.3. Ambulatory Surgical Centers
13.6.4. Academic Research Centers
13.7. Market Size (US$ Mn) Forecast By End User, 2018–2028
13.8. Market Attractiveness Analysis
13.8.1. By Product Type
13.8.2. By Application
13.8.3. By End User
13.9. Key Market Participants – Intensity Mapping
13.10. Drivers and Restraints – Impact Analysis
14. Middle East & Africa Amniotic Membrane Market Analysis 2013–2017 and Forecast 2018–2028
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
14.2.1. GCC Countries
14.2.2. South Africa
14.2.3. Rest of MEA
14.3. Market Size (US$ Mn) Forecast By Country, 2018–2028
14.4. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Product Type, 2013–2017
14.4.1. Cryopreserved Amniotic Membrane
14.4.2. Lyophilization Amniotic Membrane
14.5. Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2018–2028
14.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
14.6.1. Surgical Wound
14.6.2. Ophthalmology
14.6.3. Others
14.7. Market Size (US$ Mn) Forecast By Application, 2018–2028
14.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
14.8.1. Hospitals
14.8.2. Specialized Clinics
14.8.3. Ambulatory Surgical Centers
14.8.4. Academic Research Centers
14.9. Market Size (US$ Mn) Forecast By End User, 2018–2028
14.10. Market Attractiveness Analysis
14.10.1. By Country
14.10.2. By Product Type
14.10.3. By Application
14.10.4. By End User
14.11. Key Market Participants – Intensity Mapping
14.12. Drivers and Restraints – Impact Analysis
15. Forecast Factors: Relevance and Impact
16. Forecast Assumptions
17. Market Structure Analysis
17.1. Market Structure Analysis by Tier
17.2. Market Share Analysis (2016) for Top 10 Players, By Region
17.3. Competition Dashboard
17.4. Company Deep Dive
17.4.1. Integra LifeSciences Holdings Corporation
17.4.1.1. Product and Application Portfolio
17.4.1.2. Production Footprint
17.4.1.3. Sales Footprint
17.4.1.4. Channel Footprint
17.4.1.5. Strategy
17.4.1.5.1. Marketing Strategy
17.4.1.5.2. Product Strategy
17.4.1.5.3. Channel Strategy
17.4.2. Alliqua BioMedical,
17.4.2.1. Overview
17.4.2.2. Product and Application Portfolio
17.4.2.3. Production Footprint
17.4.2.4. Sales Footprint
17.4.2.5. Channel Footprint
17.4.2.6. Strategy
17.4.2.6.1. Marketing Strategy
17.4.2.6.2. Product Strategy
17.4.2.6.3. Channel Strategy
17.4.3. Skye Biologics Inc.
17.4.3.1. Overview
17.4.3.2. Product and Application Portfolio
17.4.3.3. Production Footprint
17.4.3.4. Sales Footprint
17.4.3.5. Channel Footprint
17.4.3.6. Strategy
17.4.3.6.1. Marketing Strategy
17.4.3.6.2. Product Strategy
17.4.3.6.3. Channel Strategy
17.4.4. Katena Products, Inc.
17.4.4.1. Overview
17.4.4.2. Product and Application Portfolio
17.4.4.3. Production Footprint
17.4.4.4. Sales Footprint
17.4.4.5. Channel Footprint
17.4.4.6. Strategy
17.4.4.6.1. Marketing Strategy
17.4.4.6.2. Product Strategy
17.4.4.6.3. Channel Strategy
17.4.5. MiMedx Group, Inc.
17.4.5.1. Overview
17.4.5.2. Product and Application Portfolio
17.4.5.3. Production Footprint
17.4.5.4. Sales Footprint
17.4.5.5. Channel Footprint
17.4.5.6. Strategy
17.4.5.6.1. Marketing Strategy
17.4.5.6.2. Product Strategy
17.4.5.6.3. Channel Strategy
17.4.6. Human Regenerative Technologies, LLC
17.4.6.1. Overview
17.4.6.2. Product and Application Portfolio
17.4.6.3. Production Footprint
17.4.6.4. Sales Footprint
17.4.6.5. Channel Footprint
17.4.6.6. Strategy
17.4.6.6.1. Marketing Strategy
17.4.6.6.2. Product Strategy
17.4.6.6.3. Channel Strategy
17.4.7. Tissue-Tech Inc.
17.4.7.1. Overview
17.4.7.2. Product and Application Portfolio
17.4.7.3. Production Footprint
17.4.7.4. Sales Footprint
17.4.7.5. Channel Footprint
17.4.7.6. Strategy
17.4.7.6.1. Marketing Strategy
17.4.7.6.2. Product Strategy
17.4.7.6.3. Channel Strategy
17.4.8. Amnio Technology, LLC
17.4.8.1. Overview
17.4.8.2. Product and Application Portfolio
17.4.8.3. Production Footprint
17.4.8.4. Sales Footprint
17.4.8.5. Channel Footprint
17.4.8.6. Strategy
17.4.8.6.1. Marketing Strategy
17.4.8.6.2. Product Strategy
17.4.8.6.3. Channel Strategy
17.4.9. Applied Biologics LLC
17.4.9.1. Overview
17.4.9.2. Product and Application Portfolio
17.4.9.3. Production Footprint
17.4.9.4. Sales Footprint
17.4.9.5. Channel Footprint
17.4.9.6. Strategy
17.4.9.6.1. Marketing Strategy
17.4.9.6.2. Product Strategy
17.4.9.6.3. Channel Strategy
18. Global Amniotic Membrane Market Analysis 2013–2017 and Forecast 2018–2028, By Region
18.1. Introduction/Key Findings
18.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2013–2017
18.3. Market Size (US$ Mn) Forecast By Region, 2018–2028
18.3.1. North America
18.3.2. Latin America
18.3.3. Western Europe
18.3.4. Eastern Europe
18.3.5. Asia Pacific Excluding Japan
18.3.6. Japan
18.3.7. China
18.3.8. Middle East & Africa
18.4. Market Attractiveness Analysis By Region
19. Global Amniotic Membrane Analysis 2013–2017 and Forecast 2018–2028, By Product Type
19.1. Introduction/Key Findings
19.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Product Type, 2013–2017
19.2.1. Cryopreserved Amniotic Membrane
19.2.2. Lyophilization Amniotic Membrane
19.3. Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2018–2028
19.4. Market Attractiveness Analysis By Product Type
20. Global Amniotic Membrane Market Analysis 2013–2017 and Forecast 2018–2028, By Application
20.1. Introduction/Key Findings
20.2. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
20.2.1. Surgical Wound
20.2.2. Ophthalmology
20.2.3. Others
20.3. Market Size (US$ Mn) Forecast By Application, 2018–2028
20.4. Market Attractiveness Analysis By Application
21. Global Amniotic Membrane Market Analysis 2013–2017 and Forecast 2018–2028, By End User
21.1. Introduction/Key Findings
21.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
21.2.1. Hospitals
21.2.2. Specialized Clinics
21.2.3. Ambulatory Surgical Centers
21.2.4. Academic Research Centers
21.3. Market Size (US$ Mn) Forecast By End User, 2018–2028
21.4. Market Attractiveness Analysis By End User
22. Global Amniotic Membrane Market Analysis 2013–2017 and Forecast 2018–2028
22.1. Market Value Share Analysis
22.2. Y-o-Y Growth Analysis
22.3. Absolute $ Opportunity
22.4. Research Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook